全文获取类型
收费全文 | 2237篇 |
免费 | 175篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 54篇 |
妇产科学 | 80篇 |
基础医学 | 331篇 |
口腔科学 | 49篇 |
临床医学 | 238篇 |
内科学 | 336篇 |
皮肤病学 | 147篇 |
神经病学 | 191篇 |
特种医学 | 53篇 |
外科学 | 181篇 |
综合类 | 17篇 |
一般理论 | 6篇 |
预防医学 | 270篇 |
眼科学 | 32篇 |
药学 | 136篇 |
中国医学 | 2篇 |
肿瘤学 | 248篇 |
出版年
2023年 | 29篇 |
2022年 | 45篇 |
2021年 | 88篇 |
2020年 | 65篇 |
2019年 | 75篇 |
2018年 | 88篇 |
2017年 | 60篇 |
2016年 | 78篇 |
2015年 | 52篇 |
2014年 | 78篇 |
2013年 | 125篇 |
2012年 | 146篇 |
2011年 | 133篇 |
2010年 | 93篇 |
2009年 | 93篇 |
2008年 | 135篇 |
2007年 | 114篇 |
2006年 | 128篇 |
2005年 | 133篇 |
2004年 | 96篇 |
2003年 | 109篇 |
2002年 | 80篇 |
2001年 | 16篇 |
2000年 | 13篇 |
1999年 | 15篇 |
1998年 | 24篇 |
1997年 | 30篇 |
1996年 | 14篇 |
1995年 | 11篇 |
1994年 | 22篇 |
1993年 | 14篇 |
1992年 | 15篇 |
1991年 | 10篇 |
1990年 | 6篇 |
1989年 | 10篇 |
1988年 | 11篇 |
1987年 | 14篇 |
1986年 | 13篇 |
1985年 | 12篇 |
1984年 | 10篇 |
1983年 | 13篇 |
1982年 | 16篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 8篇 |
1978年 | 10篇 |
1976年 | 6篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1943年 | 5篇 |
排序方式: 共有2419条查询结果,搜索用时 15 毫秒
101.
Widespread Differential Maternal and Paternal Genome Effects on Fetal Bone Phenotype at Mid‐Gestation
下载免费PDF全文
![点击此处可从《Journal of bone and mineral research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Ruidong Xiang Alice MC Lee Tanja Eindorf Ali Javadmanesh Mani Ghanipoor‐Samami Madeleine Gugger Carolyn J Fitzsimmons Zbigniew A Kruk Wayne S Pitchford Alison J Leviton Dana A Thomsen Ian Beckman Gail I Anderson Brian M Burns David L Rutley Cory J Xian Stefan Hiendleder 《Journal of bone and mineral research》2014,29(11):2392-2404
Parent‐of‐origin–dependent (epi)genetic factors are important determinants of prenatal development that program adult phenotype. However, data on magnitude and specificity of maternal and paternal genome effects on fetal bone are lacking. We used an outbred bovine model to dissect and quantify effects of parental genomes, fetal sex, and nongenetic maternal effects on the fetal skeleton and analyzed phenotypic and molecular relationships between fetal muscle and bone. Analysis of 51 bone morphometric and weight parameters from 72 fetuses recovered at day 153 gestation (54% term) identified six principal components (PC1–6) that explained 80% of the variation in skeletal parameters. Parental genomes accounted for most of the variation in bone wet weight (PC1, 72.1%), limb ossification (PC2, 99.8%), flat bone size (PC4, 99.7%), and axial skeletal growth (PC5, 96.9%). Limb length showed lesser effects of parental genomes (PC3, 40.8%) and a significant nongenetic maternal effect (gestational weight gain, 29%). Fetal sex affected bone wet weight (PC1, p < 0.0001) and limb length (PC3, p < 0.05). Partitioning of variation explained by parental genomes revealed strong maternal genome effects on bone wet weight (74.1%, p < 0.0001) and axial skeletal growth (93.5%, p < 0.001), whereas paternal genome controlled limb ossification (95.1%, p < 0.0001). Histomorphometric data revealed strong maternal genome effects on growth plate height (98.6%, p < 0.0001) and trabecular thickness (85.5%, p < 0.0001) in distal femur. Parental genome effects on fetal bone were mirrored by maternal genome effects on fetal serum 25‐hydroxyvitamin D (96.9%, p < 0.001) and paternal genome effects on alkaline phosphatase (90.0%, p < 0.001) and their correlations with maternally controlled bone wet weight and paternally controlled limb ossification, respectively. Bone wet weight and flat bone size correlated positively with muscle weight (r = 0.84 and 0.77, p < 0.0001) and negatively with muscle H19 expression (r = –0.34 and –0.31, p < 0.01). Because imprinted maternally expressed H19 regulates growth factors by miRNA interference, this suggests muscle‐bone interaction via epigenetic factors. © 2014 American Society for Bone and Mineral Research. 相似文献
102.
Helminth parasites infect an alarmingly large proportion of the world's population, primarily within tropical regions, and their ability to down-modulate host immunity is key to their persistence. Helminths have developed multiple mechanisms that induce a state of hyporesponsiveness or immune suppression within the host; of particular interest are mechanisms that drive the induction of regulatory T-cells (Tregs). Helminths actively induce Tregs either directly by secreting factors, such as the TGF-β mimic Hp-TGM, or indirectly by interacting with bystander cell types such as dendritic cells and macrophages that then induce Tregs. Expansion of Tregs not only enhances parasite survival but, in cases such as filarial infection, Tregs also play a role in preventing parasite-associated pathologies. Furthermore, Tregs generated during helminth infection have been associated with suppression of bystander immunopathologies in a range of inflammatory conditions such as allergy and autoimmune disease. In this review, we discuss evidence from natural and experimental infections that point to the pathways and molecules involved in helminth Treg induction, and postulate how parasite-derived molecules and/or Tregs might be applied as anti-inflammatory therapies in the future. 相似文献
103.
Harshida Patel Grazyna Szkinc-Olsson Madeleine Lennartsson Al Liddawi 《国际护理科学(英文)》2021,(3):279-288,后插3
目的 以往关于心力衰竭患者自我照顾的研究强调了其重要性,特别对移民患者而言.护士在为慢性病(如心力衰竭)患者提供相关信息并促进他们积极进行自我照顾方面发挥着重要作用.本研究旨在加强研究者及护士的认识,为患有心力衰竭的移民的自我照顾提供最佳支持.方法 采用质性研究方法.2020年10-12月,对瑞典西部不同类型机构心力衰... 相似文献
104.
105.
106.
Madeleine E. Cunningham Gavin R. Meehan Sophie Robinson Denggao Yao Rhona McGonigal Hugh J. Willison 《Journal of the peripheral nervous system : JPNS》2020,25(2):143-151
In mouse models of acute motor axonal neuropathy, anti‐ganglioside antibodies (AGAbs) bind to motor axons, notably the distal nerve, and activate the complement cascade. While complement activation is well studied in this model, the role of inflammatory cells is unknown. Herein we aimed to investigate the contribution of phagocytic cells including macrophages, neutrophils and perisynaptic Schwann cells (pSCs) to distal nerve pathology. To observe this, we first created a subacute injury model of sufficient duration to allow inflammatory cell recruitment. Mice were injected intraperitoneally with an anti‐GD1b monoclonal antibody that binds strongly to mouse motor nerve axons. Subsequently, mice received normal human serum as a source of complement. Dosing was titrated to allow humane survival of mice over a period of 3 days, yet still induce the characteristic neurological impairment. Behaviour and pathology were assessed in vivo using whole‐body plethysmography and post‐sacrifice by immunofluorescence and flow cytometry. ex vivo nerve‐muscle preparations were used to investigate the acute phagocytic role of pSCs following distal nerve injury. Following complement activation at distal intramuscular nerve sites in the diaphragm macrophage localisation or numbers are not altered, nor do they shift to a pro‐ or anti‐inflammatory phenotype. Similarly, neutrophils are not significantly recruited. Instead, ex vivo nerve‐muscle preparations exposed to AGAb plus complement reveal that pSCs rapidly become phagocytic and engulf axonal debris. These data suggest that pSCs, rather than inflammatory cells, are the major cellular vehicle for axonal debris clearance following distal nerve injury, in contrast to larger nerve bundles where macrophage‐mediated clearance predominates. 相似文献
107.
108.
Background: In 2013, the group of Cicero Coimbra, Brazil, reported the clinical efficacy of high doses of vitamin D3 in patients suffering from autoimmune skin disorders (“Coimbra protocol”, CP). However, hypercalcemia and the subsequent impaired renal function may be major concerns raised against this protocol. Methods: We report for the first time for a broad spectrum of autoimmune diseases in 319 patients (mean age (±SD) 43.3 ± 14.6 years, 65.5% female, 34.5% male) safety data for high doses of orally applied vitamin D3 (treatment period: up to 3.5 years) accompanied by a strict low-calcium diet and regular daily fluid intake of at least 2.5 L. Results: Mean vitamin D3 dose was 35,291 ± 21,791 IU per day. The measurement of more than 6100 single relevant laboratory parameters showed all mean values (±SD) within the normal range for total serum calcium (2.4 ± 0.1 mmol/L), serum creatinine (0.8 ± 0.2 mg/dL), serum creatinine associated estimated GFR (92.5 ± 17.3 mL/min), serum cystatin C (0.88 ± 0.19 mg/L), serum TSH (1.8 ± 1 mIU/L), and for 24 h urinary calcium secretion (6.9 ± 3.3 mmol/24 h). We found a very weak relationship between the dosage of oral vitamin D3 and the subsequent calcium levels, both in serum and in urinary excretion over 24 h, respectively. Conclusions: Our data show the reliable safety of the CP in autoimmune patients under appropriate supervision by experienced physicians. 相似文献
109.
Blepharophimosis,short humeri,developmental delay and hirschsprung disease: Expanding the phenotypic spectrum of MED12 mutations
下载免费PDF全文
![点击此处可从《American journal of medical genetics. Part A》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Bertrand Isidor Tiphaine Lefebvre Claudine Le Vaillant Gaëlle Caillaud Laurence Faivre Frédéric Jossic Madeleine Joubert Norbert Winer Cédric Le Caignec Guntram Borck Anna Pelet Jeanne Amiel Annick Toutain Nathalie Ronce Martine Raynaud Alain Verloes Albert David 《American journal of medical genetics. Part A》2014,164(7):1821-1825
110.
Jonathan L. Curry Michael T. Tetzlaff Priyadharsini Nagarajan Carol Drucker Adi Diab Sharon R. Hymes Madeleine Duvic Wen‐Jen Hwu Jennifer A. Wargo Carlos A. Torres‐Cabala Ronald P. Rapini Victor G. Prieto 《Journal of cutaneous pathology》2017,44(2):158-176
Immunomodulatory drugs that leverages host immune mechanisms to destroy tumor cells have been met with great promise in the treatment of cancer. Immunotherapy, targeting cytotoxic T‐lymphocyte‐associated antigen 4 (CTLA‐4) and the programmed cell death 1 (PD‐1) receptor and its ligand (PD‐L1) have shown tremendous improvements in the survival of patients with advanced solid tumors. However, the development of dermatologic toxicity (DT) is a consequence to immunotherapy. Review of published reports of the DT to immunotherapy revealed patients receiving anti‐CTCLA‐4 antibody or anti‐PD‐1/PD‐L1 antibody often develop a DT of any type and grade. In this article, of the 3825 patients who were treated with anti‐PD‐1 and of 556 patients receiving anti‐PD‐L1, DT of any type and grade were reported in 1474 (~39%) and 95 (~17%) of patients, respectively. The emergence of specific types of DT to immunotherapy is beginning to be recognized can be categorized into four groups: (a) inflammatory, (b) immunobullous, (c) alteration of keratinocytes and (d) alteration of melanocytes. Lichenoid dermatitis and bullous pemphigoid appear to be DT more associated with anti‐PD‐1/PD‐L1 antibody. The DT profile in patients receiving immunotherapy is diverse, and early recognition of specific types of DT that clinicians may encounter is critical for optimal patient care 相似文献